These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
729 related articles for article (PubMed ID: 8384448)
1. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid. Packham MA; Livne AA; Ruben DH; Rand ML Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448 [TBL] [Abstract][Full Text] [Related]
2. Exogenous diacylglycerols synergize with PAF with human platelets, but inhibit PAF-induced responses of rabbit platelets. Packham MA; Ruben DH; Rand ML J Lipid Mediat Cell Signal; 1996 Dec; 15(1):69-87. PubMed ID: 9029375 [TBL] [Abstract][Full Text] [Related]
3. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets. Nunn DL; Watson SP Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion. Joseph S; Krishnamurthi S; Kakkar VV Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002 [TBL] [Abstract][Full Text] [Related]
5. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP; Maguire MH Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500 [TBL] [Abstract][Full Text] [Related]
6. The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin. Watson SP; McNally J; Shipman LJ; Godfrey PP Biochem J; 1988 Jan; 249(2):345-50. PubMed ID: 3257691 [TBL] [Abstract][Full Text] [Related]
7. A role of diacylglycerol kinase in stimulus-secretion coupling of human platelets. Dissociation of serotonin secretion from Ca2+ mobilization. Tohmatsu T; Nakashima S; Hattori H; Suganuma A; Nozawa Y Thromb Res; 1987 Jul; 47(1):25-35. PubMed ID: 2821648 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets. Iorio P; Gresele P; Stasi M; Nucciarelli F; Vezza R; Nenci GG; Goracci G FEBS Lett; 1996 Mar; 381(3):244-8. PubMed ID: 8601464 [TBL] [Abstract][Full Text] [Related]
9. The diacylglycerol kinase inhibitor, R59022, potentiates cholecystokinin-induced enzyme secretion from rabbit pancreatic acini. Ederveen AG; van Emst-de Vries SE; De Pont JJ; Willems PH Eur J Biochem; 1990 Mar; 188(2):333-8. PubMed ID: 1690650 [TBL] [Abstract][Full Text] [Related]
10. 1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type. Krishnamurthi S; Joseph S; Kakkar VV Eur J Biochem; 1987 Sep; 167(3):585-93. PubMed ID: 3653105 [TBL] [Abstract][Full Text] [Related]
11. Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C. Walker TR; Watson SP Br J Pharmacol; 1992 Mar; 105(3):627-31. PubMed ID: 1628149 [TBL] [Abstract][Full Text] [Related]
12. The inhibition of arachidonic acid mobilization in human platelets by R59 022, a diacylglycerol kinase inhibitor. Mahadevappa VG; Sicilia FJ Biochim Biophys Acta; 1988 Aug; 961(3):309-15. PubMed ID: 2840967 [TBL] [Abstract][Full Text] [Related]
13. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. de Chaffoy de Courcelles DC; Roevens P; Van Belle H J Biol Chem; 1985 Dec; 260(29):15762-70. PubMed ID: 2999135 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]
16. Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors. Bishop WR; August J; Petrin JM; Pai JK Biochem J; 1990 Jul; 269(2):465-73. PubMed ID: 2386487 [TBL] [Abstract][Full Text] [Related]
17. The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin. Si-Tahar M; Renesto P; Falet H; Rendu F; Chignard M Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):401-8. PubMed ID: 8573071 [TBL] [Abstract][Full Text] [Related]
18. Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. Mey. Ko FN; Chang YL; Kuo YH; Lin YL; Teng CM Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):321-7. PubMed ID: 8216237 [TBL] [Abstract][Full Text] [Related]
19. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C. Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131 [TBL] [Abstract][Full Text] [Related]
20. Induction of the fibrinogen receptor on human platelets by intracellular mediators. Shattil SJ; Brass LF J Biol Chem; 1987 Jan; 262(3):992-1000. PubMed ID: 3100533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]